>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Voices Opposition to CMS Pain Proposal

Tuesday, September 04, 2012

On September 4, 2012, ASA voiced official opposition to the Centers for Medicare and Medicaid Services’ (CMS) proposal to create a new national payment policy for the diagnosis and treatment of chronic pain services by nurse anesthetists. The proposal is found in the “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face to Face Encounters, etc (CMS-1590-P)” proposed rule. 

ASA expressed its opposition:  

"As the medical specialty representing the largest number of practicing pain medicine physicians and the recognized leaders in patient safety, ASA is extremely disappointed with the Centers for
Medicare and Medicaid Services’ (CMS) proposal to create a new national payment policy to pay for chronic pain services delivered by CRNAs or nurse anesthetists."

This comment letter follows over 1,750 ASA members who have submitted comments opposing the proposal.

ASA will continue to work with federal agencies and Congress to oppose this proposal.

The letter also provides ASA's perspective on other provisions contained in the proposed rule.

Review the letter.
Review attachments to the letter.

« Back to Washington Alerts